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Background: Since chronic fatigue syndrome (CFS) and fibromyalgia (FM) often co-exist, some believe they reflect
the same process, somatization. Against that hypothesis are data suggesting FM but not CFS was common in
patients with sleep-disordered breathing (SDB). The presence of discrete case definitions for CFS and FM
allowed us to explore rates of CFS alone, CFS with FM, and FM alone in SDB patients compared to those with
sleep complaints that fulfilled criteria for insomnia.
Methods: Participants were 175 sequential patients with sleep-related symptoms (122 had SDB and 21 had
insomnia) and 39 healthy controls. Diagnoses were made by questionnaires, tender point count, and rule out
labs; sleepiness was assessed with Epworth Sleepiness Scale and mood with Beck Depression Inventory.
Results: Rates of CFS, FM or CFS + FM were high: 13% in SDB and 48% in insomnia. CFS occurred frequently in
SDB and insomnia, but FM occurred frequently only in insomnia. SDB patients with CFS and/or FM had higher
daytime sleepiness than those without these disorders.
Conclusion: CFS patients should complete Epworth scales, and sleep evaluation should be considered for those
with scores ≥ 16 before receiving the diagnosis of CFS; the coexistence of depressed mood in these patients
suggests some may be helped by treatment of their depression. That FM was underrepresented in SDB suggests
FM and CFS may have different underlying pathophysiological causes.
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Chronic fatigue syndrome (CFS) and fibromyalgia (FM)
are symptom-based illnesses, diagnosed using sets of
clinical criteria agreed upon by experts [1,2]. However
the core symptoms of pain, fatigue, sleep problems and
cognitive difficulties exist across both syndromes and
lead to significant co-morbidity between them. The fact
that these two syndromes co-exist so often has led some
to question whether they are, in fact, distinct diagnostic
entities. Wessely et al. [3], for example, have suggested
that the “similarities between them outweigh the dif-
ferences” and Barsky and Borus [4], noting similarities* Correspondence: bnatelson@bethisraelny.org
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unless otherwise stated.between CFS and FM, suggested an explanatory model
based on the concept of symptom amplification – that is,
a common psychological tendency to somatize or miscon-
strue the significance of normal physical sensation. We
have termed this the “unitary” hypothesis. If that hypoth-
esis were true, discrete case definitions corresponding to
distinct illness syndromes would be unnecessary. How-
ever, there is substantial evidence against this interpret-
ation showing that CFS can differ from FM [5] – thus
providing evidence against the unitary hypothesis. Finding
these differences argues for the two illnesses being differ-
ent – with different underlying pathophysiology.
The underlying causes of disturbed and/or unrefresh-
ing sleep, common complaints in both CFS and FM, re-
main to be more fully considered – specifically as to
whether rates of sleep pathology differ between CFS and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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considered exclusions for the diagnosis of CFS, formal
sleep evaluation including polysomnography (PSG) was
not recommended in evaluating a patient with severe fa-
tigue [1]. That decision seemed appropriate because, in
contrast to early studies that suggested a high rate of
sleep disorders in CFS [6-8], later studies including our
own found no difference in rates of sleep disorders be-
tween patients with CFS and healthy controls [9-11]. In
contrast, except for our own work [11] and one other
early study [12], a number of other studies suggests that
FM is often accompanied by sleep-disordered breathing
(SDB) [13-16].
Existing case definitions allow for the diagnosis of ei-
ther disorder occurring alone or CFS and FM occurring
together. Because prior studies of symptom-based illness
usually did not differentiate between CFS or FM [5], we
thought that research on the relation among CFS alone,
FM alone, CFS with FM and sleep diagnosis might fur-
ther understanding about the pathophysiological under-
pinnings of these syndromes. To do this, we evaluated a
consecutive cohort of patients with sleep complaints for
these diagnoses; the patients then underwent diagnostic
PSG. Based on the literature, we expected to find in-
creased rates of FM but not of CFS in patients with
SDB. Our plan was to compare these data to those in
patients with insomnia, i.e., sleep complaints with PSG-
based evidence of increased sleep latency, prolonged pe-
riods of wakefulness following sleep onset, or early
morning awakening. Since disturbed sleep is a complaint
common to both CFS and FM, we expected to find high
rates of both these illnesses in these patients. Finally, we
also evaluated patients for irritable bowel syndrome
(IBS), because it is known to co-exist with FM and CFS




Participants were 175 patients and 39 healthy controls,
aged ≥18 and body mass index (BMI) ≤40. Patients were
a consecutive series of people with sleep-related symptoms
(breath cessations, snoring, excessive daytime sleepiness,
fatigue, difficulty initiating or maintaining sleep or early
morning awakening) who underwent diagnostic polysom-
nography followed by evaluation by a sleep specialist be-
tween June 2006 and June 2007 at the Sleep Research and
Treatment Center and were found to have a primary sleep
disorder. A wide variety of practitioners in central Pennsyl-
vania, i.e., primary care as well as specialty physicians’ of-
fices, referred these patients in order to rule out primary
sleep disorder; none of the patients was referred by the
Pain & Fatigue Study Center in New Jersey. Controls
were Dauphin county residents, taking no medications,in good health with neither sleep-related complaints
nor wide spread pain. All subjects signed their in-
formed consent to participate in this study which was
approved by Penn State College of Medicine’s Institu-
tional Review Board.
Sequence of procedures
Assessment of fatigue and pain, sleepiness, and depression
On entry to the Sleep Research and Treatment Center,
one of the medical doctors involved in this study (SP,
MB, and FM) did a medical evaluation on each patient,
including medical and sleep history, a physical examin-
ation including a tender point examination, and clinical
tests (including complete cell blood count; liver and renal
profiles; glucose; thyroid indices and an electrocardiogram).
Patients were then asked to complete a questionnaire
assessing medical and psychiatric symptoms developed
and used extensively by one of the authors, BHN, to
identify patients with CFS, fibromyalgia, and irritable
bowel syndrome (http://www.painandfatigue.com/).
Immediately thereafter, daytime sleepiness and mood
were assessed by Epworth Sleepiness Scale (ESS) and
Beck Depression Inventory (BDI), respectively [18,19].
BDI results did not change when the items related to
sleep disturbance and fatigue were eliminated from the
total BDI score.
Diagnosis of FM and Chronic Fatigue Syndrome (CFS)
The diagnosis of FM was made using the 1990 case def-
inition [2]: existence of chronic widespread pain plus
tenderness on palpation in at least 11 of 18 tender point
sites. Pain was considered chronic and widespread if pa-
tients indicated on the questionnaire that it existed over
the past 3 months in: (1) shoulders, arms or hands on
both left and right side of the body, (2) legs or feet on
left and right sides, and (3) chest, neck or back on both
left and right sides as reported in the intake question-
naire. A tender point was counted if the patient reported
severity of pain during palpation with 4 kg of force to
be ≥ 2 on a scale from 0 to 10, with 0 meaning no pain
and 10 meaning worst pain possible [20].
Patients were diagnosed with chronic fatigue syn-
drome if they fulfilled the 1994 case definition [1]. Spe-
cifically, patients responded to a five point visual analog
scale in the intake questionnaire to rate the degree fa-
tigue had reduced their activity; to be included, patients
had to indicate that their fatigue had had a substantial,
severe, or very severe effect (ascertained by scores of ≥3
on a 0 to 5 scale where 3 was substantial, 4 severe and 5
very severe) on their level of activity on the job, in
school or class, socially, or in their personal life. Next,
patients were asked about the duration they had suffered
from the following symptoms: sore throat, tender lymph
glands, headache, myalgia, arthralgia, unrefreshing sleep,
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exertion produced a dramatic worsening of their entire
symptom complex; to be included, patients had to report
that at least 4 of these symptoms had been a problem for
at least 6 months with severity in the month prior to in-
take rated as ≥3 on 0 to 5 visual analog scales where 0 was
none, 1 mild, 2 moderate, 3 substantial, 4 severe, and 5
very severe. Finally, to receive the diagnosis of CFS, pa-
tients had to have normal results on laboratory tests. The
existence of independent diagnostic criteria for CFS and
for FM allowed the identification of patients fulfilling diag-
nostic criteria for either or both disorders.
Diagnosis of Irritable Bowel Syndrome (IBS)
Diagnosis of IBS required patients to fulfill ROME II cri-
teria – i.e., at least 12 weeks, not necessarily consecutive,
in the preceding year of abdominal discomfort or pain
that had two of three features: relieved with defecation;
onset associated with change in frequency of daily bowel
movements from normal to >3/day or to <3/week; onset
associated with a change in form from normal to lumpy/
hard or to loose/watery in the intake questionnaire [21].
Sleep laboratory recordings
Immediately after these procedures, subjects were evalu-
ated for one night for 8 h (2300–0700) in sound attenu-
ated, light and temperature controlled rooms following
standard polysomnographic procedures with continuous
multi-channel monitoring of electroencephalogram (3
channels), electro-oculogram (3 channels), and electro-
myogram (1 channel). Sleep records were subsequently
scored independently, according to standardized criteria
[22]. Respiration was monitored throughout the night by
nasal and oral thermocouples (model TCT 1R, Grass In-
strument, Quincy, MA), and by nasal pressure transducer
(MP45-871 ± 2 cm H20, Validyne Engineering Corp.) and
thoracic strain gauges. All-night recordings of hemoglobin
oxygen saturation (SaO2) were obtained with a cardio-
respiratory oximeter (Model 8800, Noonin Medical,
Plymouth, MN) attached to the finger. “Apneas” were
breath cessations exceeding 10 seconds; “hypopneas”,
airflow reductions of ~50% with 3% reduction of SaO2.
“Apnea-hypopnea index” (AHI) was the number of ap-
neas and/or hypopneas/hr of sleep. “Respiratory dis-
turbance index” (RDI) was AHI plus the number of
breathing related arousals/hr of sleep – i.e., number of
EEG arousals associated with reduction in airflow of ~30%
without 3% reduction of SaO2 [23]. The RDI including
nasal cannula/pressure transducer flow limitation events
terminated by arousal has been previously shown to be es-
sentially identical to the number of the esophageal man-
ometry events terminated by arousal, which have been
called Respiratory Effort-Related Arousals [24]. “Periodic
leg movements” (PLMS) were counted if lasting from 0.5to 5 seconds and in intervals of less than 90 seconds be-
tween movements. “PLMS index” was number of periodic
leg movements/hour of sleep.
The next morning, subjects were evaluated by the
sleep specialists of the Sleep Research and Treatment
Center and were diagnosed with primary sleep disorder`
(s) if they met International Classification of Sleep Disor-
ders criteria [25]. Then, patients, who by history and/or
PSG had evidence of having hypersomnias of central
origin (either idiopathic hypersomnia or narcolepsy),
underwent two 60 min daytime naps at approximately
9:00 AM and 12:30 PM [26]; this protocol provides a
quantitative assessment of pathological diurnal sleepi-
ness and has been suggested as an alternative to the
Multiple Sleep Latency Test in the evaluation of pa-
tients with these disorders [27].
We used two PSG-based criteria to define clinically
significant sleep-disordered breathing: (1) an AHI <5 events/
hr with an RDI >10 or (2) an AHI ≥5 events/hr. In addition,
to receive the diagnosis of SDB, patients fulfilling either
criterion had to also have daytime sleepiness/fatigue and/or
cardiovascular problems i.e., hypertension. Healthy controls
did not fulfill criteria for any sleep diagnosis.
Statistical analysis
Subjects were classified into four “sleep diagnosis groups”
(SDB, insomnia, idiopathic hypersomnia, and narcolepsy)
according to their primary diagnosis. The SDB group was
comprised of patients diagnosed as having sleep disturbed
breathing; the insomnia group included patients diag-
nosed as having insomnia as defined by ICSD-2 general
criteria for the disorder; the idiopathic hypersomnia group
included patients diagnosed as having idiopathic hyper-
somnia; and the narcolepsy group included patients di-
agnosed by narcolepsy with or without cataplexy. To
maintain group homogeneity, we made the post hoc
decision to exclude patients with more than one sleep
diagnosis as follows: 3 hypersomnia patients with AHIs
between 5 and 14; two narcolepsy patients – one with
AHI < 5 and RDI > 10 and one with AHI between 5 and
14; six patients with insomnia (three with AHI values
between 5 and 14 and three with values ≥ 15); and
three patients with RLS (2 with AHIs > 15 and 1 with
insomnia). Two subjects with other primary sleep diag-
noses were not included in the analysis because of
small cell sizes: one with sleepwalking and the other
with delayed sleep-phase syndrome. Dropping these 16
subjects reduced our evaluable sample to 159.
Because sample sizes of patients with idiopathic hyper-
somnia and narcolepsy were small (n = 10 and 6, re-
spectively), we did not include them in further analyses
but provide data on frequency of CFS and/or FM (20%
and 50% respectively; see results for breakdown of CFS
and FM diagnosis) to stimulate further research on their
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to compare subjects across the remaining three study
groups (healthy controls, SDB, and insomnia) as to age
and BMI. We used Chi square testing to determine if
rates of symptom-based illnesses varied between the
sleep disorders. We used multivariate logistic regression
to examine if the difference in rates of symptom-based
illnesses persisted after controlling for gender, age, and
RDI. The same analysis was used to assess the roles of
AHI, sleep efficiency, BMI, presence of symptom-based
illness and BDI score in affecting sleepiness in SDB.
Analysis of covariance was used to test the differences in
BDI scores between the two sleep disorders groups with
or without symptom-based illnesses and healthy controls
as well as if differences in BDI scores existed between
patients with zero, one, two or three unexplained syndromes.
A similar approach was used to determine if differences in
sleepiness existed between the two sleep disorder groupsTable 1 Detailed breakdown of characteristics of patients wit
All SDB = 122
Low AHI = 36
Men = 18 → No CFS/FM = 16→
CFS/FM = 2→
Women = 18→ No CFS/FM = 14→
CFS/FM = 4→
High AHI = 86
Men = 65 → No CFS/FM = 59→
CFS/FM = 6→
Women = 21→ No CFS/FM = 17→
CFS/FM = 4→
We are presenting data stratifying the ESS data by scores 16 or higher; this was the
We are presenting Beck data two ways: with the cut off at 20 [moderate depressed
20 cut off.with or without symptom-based illnesses. Flowcharts for
the SDB and insomnia group are provided [see Tables 1
and 2]. Analysis of covariance was also used to examine
differences between the two sleep disorders groups with
or without symptom-based illnesses and healthy controls
in PSG variables.
Data in the text are presented as mean (SD). P < 0.05
was considered statistically significant.
Results
Sleep disorders
Of the 159 evaluable patients with sleep complaints who
underwent PSG, 122 (77%) patients were diagnosed with
sleep disturbed breathing, 21 (13%) with insomnia (for
SDB and insomnia, see Table 3), 10 (6%) with idiopathic
hypersomnia, and 6 (4%) with narcolepsy.
Of the patients with SDB, 36 (30%) had AHIs ranging
from 5 to 14 while 86 (70%) had AHIs equal or greaterh SDB
ESS≥ 16 = 0 → Beck < 20 = 0; Beck≥ 20 = 0
ESS < 16 = 16 → Beck < 20 = 16; Beck≥ 20 = 0
ESS≥ 16 = 1 → Beck < 20 = 1; Beck≥ 20 = 0
ESS < 16 = 1 → Beck < 20 = 1; Beck≥ 20 = 0
ESS≥ 16 = 1 → Beck < 20 = 1; Beck≥ 20 = 0
→ Beck < 14 = 0; Beck≥ 14 = 1
ESS < 16 = 13 → Beck < 20 = 12; Beck≥ 20 = 1
→ Beck < 14 = 10; Beck≥ 14 = 3
ESS≥ 16 = 3 → Beck < 20 = 2; Beck≥ 20 = 1
ESS < 16 = 1 → Beck < 20 = 1; Beck≥ 20 = 0
ESS≥ 16 = 7 → Beck < 20 = 6; Beck≥ 20 = 1
→ Beck < 14 = 5; Beck≥ 14 = 2
ESS < 16 = 52 → Beck < 20 = 49; Beck≥ 20 = 3
ESS≥ 16 = 1 → Beck < 20 = 1; Beck≥ 20 = 0
→ Beck < 14 = 0; Beck≥ 14 = 1
ESS < 16 = 5 → Beck < 20 = 4; Beck≥ 20 = 1
→ Beck < 14 = 3; Beck≥ 14 = 2
ESS≥ 16 = 5 → Beck < 20 = 5; Beck≥ 20 = 0
→ Beck < 14 = 4; Beck≥ 14 = 1
ESS < 16 = 12 → Beck < 20 = 12; Beck≥ 20 = 0
→ Beck < 14 = 10; Beck≥ 14 = 2
ESS≥ 16 = 2 → Beck < 20 = 1; Beck≥ 20 = 1
→ Beck < 14 = 0; Beck≥ 14 = 2
ESS < 16 = 2 → Beck < 20 = 2; Beck≥ 20 = 0
median value for SDB patients fulfilling diagnostic criteria for CFS and/or FM.
mood] and at 14 [mild depressed mood] if data differed from those using the
Table 2 Detailed breakdown of characteristics of patients with insomnia
Insomnia (n = 21)
Men (n = 8)→ No CFS/FM =4 → Beck≥ 20 = 1→ ESS ≥ 16 = 0; ESS < 16 = 1
Beck < 20 = 3 → ESS ≥ 16 = 0; ESS < 16 = 3
CFS/FM = 4 → Beck≥ 20 = 2→ ESS ≥ 16 = 1; ESS < 16 = 1
Beck < 20 = 2 → ESS ≥ 16 = 0; ESS < 16 = 2
Women (n = 13)→ No CFS/FM =7 → Beck≥ 20 = 1→ ESS ≥ 16 = 0; ESS < 16 = 1
Beck < 20 = 6 → ESS ≥ 16 = 0; ESS < 16 = 6
CFS/FM = 6 → Beck≥ 20 = 3→ ESS ≥ 16 = 1; ESS < 16 = 2
Beck < 20 = 3 → ESS ≥ 16 = 1; ESS < 16 = 2
We are presenting the Beck data stratified by scores of 20 or higher. An analysis stratifying with scores of 14 or higher produced very similar results. We are
presenting data stratifying the ESS data by scores 16 or higher; this was the median value for SDB patients fulfilling diagnostic criteria for CFS and/or FM.
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fulfilled criteria for obstructive sleep apnea. The only dif-
ference between the two SDB groups was in gender (see
Table 3): 50% of the 36 SDB patients in the group with
lower AHIs were women compared to 24% of the 86
SDB patients in the severe group (Fishers test = .001).
Comparing the combined SDB patient group with that
of patients with insomnia, those with SDB were signifi-
cantly older and more likely to be male (Table 3).Symptom-based syndromes – fibromyalgia, chronic
fatigue syndrome and irritable bowel syndrome
As defined by our intake criteria, none of the controls
had CFS or fibromyalgia. In contrast, patients with SDB
and insomnia had appreciable rates of CFS and/or FM –
13% and 48%, respectively (see Table 3). However, while
insomnia patients showed a relatively even split between
CFS and FM, SDB patients showed predominately CFS
with low rates of FM – similar to the 3% rate seen in the
general population [28]; in contrast to the insomnia group
which had patients with FM only, the few cases of FM that
did occur in the SDB group occurred concomitantly with
CFS. The apparent difference in rates between SDB and
insomnia remained significant after controlling for gender
and age (p = 0.012). There was no substantial difference in
constitution of symptom-based diagnoses between pa-
tients with lower AHIs compared to those with high AHIs
(Low AHI: 0% FM, 14% CFS, 3% CFS + FM; High AHI: 0%
FM, 8% CFS, 4% CFS + FM).
Using data from the entire sample of 159 evaluable pa-
tients, the diagnosis of CFS alone occurred most often
(n = 18), CFS and FM next most often (n = 8), and FM
alone least often (n = 5); this also is different from what
one might expect in that rates of FM in the general
population are ten times higher than those for CFS. Of
the 10 patients with idiopathic hypersomnia, none had
CFS only or CFS + FM, and 2 had FM only. Of the 6 pa-
tients with narcolepsy, 2 had CFS only, 1 had CFS + FM
and none had FM only.One control subject had IBS alone. Nine of the SDB
patients had IBS [7 alone, 1 with CFS, and 1 with CFS +
FM]; three of the insomnia patients had IBS [1 alone; 1
with FM and, 1 with CFS + FM].Mood
Mood as measured by BDI did not differ significantly for
sleep diagnosis groups without symptom-based syndromes
compared to healthy controls (2.6 ± 3.0 [SD], healthy con-
trols; 6.2 ± 6.9, SDB; 8.9 ± 7.8, insomnia). However, when
SDB or insomnia co-existed with CFS and/or fibromyalgia,
BDI scores were significantly higher (14.0 ± 11.0 and 20.9 ±
11.6, respectively) than in controls (2.6 ± 3.0; all p’s = 0.000)
indicating more depressed mood; this effect remained after
controlling for gender and age.
As the number of symptom-based diagnoses increased,
BDI scores increased monotonically: lowest in patients
with no symptom-based diagnoses (5.5 ± 5.8 [SD]), signifi-
cantly higher in patients with one (11.9 ± 11.7; p =0.000),
significantly higher yet in patients with two (19.0 ± 10.2; p <
0.05) and higher again, albeit not significantly, in patients
with three symptom-based illnesses (30.5 ± 3.5).Subjective daytime sleepiness
As expected, patients with insomnia or with SDB were
sleepier on the Epworth Sleepiness Scale than controls,
respectively (9.4 ± 5.4 [SD]; 9.9 ± 5.2, 6.1 ± 3.8; p = 0.044
and p = 0.000, respectively). The existence of co-morbid
symptom-based syndromes affected sleepiness scores for
patients with SDB but not for those with insomnia: SDB
patients with CFS or CFS + FM had significantly higher
ESS scores than those without (13.3 ± 4.5 and 9.4 ± 5.1,
respectively, p < 0.05); of the 16 patients in this group,
63% had ESS scores >10 (Mdn = 16; IQR = 14.8, 17.3).
The significant difference between SDB patients with and
without symptom-based syndromes disappeared when
Beck Depression Scores and sleep efficiency values were
entered into the regression – leaving these latter vari-
ables significant (p = 0.003 and p = 0.003, respectively).




(AHI 5–14; n = 36)
SDB







Men, % (n) 44 (17) 50 (18) 76 (65) 68 (83) 38 (9) .009
Age (SD), y 42.9 (15.0) 50.3 (11.2) 51.8 (12.0) 51.4 (11.7) 37.8 (8.7) .000
BMI (SD), kg/m2 25.1 (4.0) 30.7 (5.0) 31.6 (4.2) 31.3 (4.5) 29.4 (5.2) .070
AHI (SE) 1.8 (0.3) 9.6 (0.6) 39.7 (2.5) 30.8 (2.1) 1.9 (0.3) .000
RDI (SE) 2.8 (0.4) 12.2 (0.8) 42.2 (2.4) 33.3 (2.1) 2.7 (0.4) .000
FM only, % (n) 0 (0) 0 (0) 0 (0) 0 (0) 14 (3) .003
CFS only, % (n) 0 (0) 14 (5) 8 (7) 10 (12)1 19 (4)3 .189
CFS + FM, % (n) 0 (0) 3 (1) 4 (3) 3 (4)2 14 (3)4 .065
No CFS or FM, % (n) 100 (39) 83 (30) 88 (76) 87 (106) 52 (11) .001
With CFS or FM, % (n) 0 (0) 17 (6) 12 (10) 13 (16) 48 (10) .001
SDB = sleep disordered breathing; BMI = body mass index; FM = fibromyalgia; CFS = chronic fatigue syndrome.
1One man in this group had well controlled diabetes and well controlled hypertension.
2One woman in this group had well controlled diabetes and well controlled hypothyroidism.
3One man in this group had well controlled hypothyroidism.
4Two women in this group had well controlled hypertension.
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The existence of CFS and/or FM did not alter standard
sleep characteristics of sleep duration and architecture,
and only minor differences in sleep characteristics were
seen (data not shown).Discussion
The results of this study lead to two main discussion
points – whether CFS and FM are the same or differ-
ent illnesses and whether patients with these clinical
diagnoses may actually have SDB as the cause of their
symptoms.
Concerning the first point, a review of the literature
suggested that FM and CFS might be different disease
processes in that SDB was reported to be common in
FM while several studies, including our own [9-11], indi-
cate SDB is not common in CFS. One study reported
finding SDB to occur in men but not women with FM
[13], and two others reported finding SDB at high rates
in women with FM [14,15]. We did not find an in-
creased rate of FM in our earlier study of sleep charac-
teristics in patients with CFS alone or CFS plus FM [11].
Two small studies used the approach we had taken here
of evaluating patients with PSG-proven SDB for FM.
One study found no increase in FM in SDB [12] while
the second did [16]. We expect these discrepancies may
be due to methodological differences related to our ex-
cluding patients with multiple sleep diagnoses and/or is-
sues related to sample size. In contrast to those reports
reporting an increased rate of FM in SDB, we found an
actual dissociation between the diagnosis of FM and
SDB. None of our SDB patients had FM alone and only
3% – the same rate as seen in the general population for
FM [28] – had FM with CFS.Because CFS and FM co-exist for a substantial number
of patients, some researchers have suggested both ail-
ments fall within the category of somatic amplification,
having functional or psychogenic rather than organic
bases [3,4]. The data reported here provide two pieces of
evidence against that interpretation. First, if CFS, FM and
IBS were all variants of a similar psychological process,
Beck scores should be the same for patients bearing the
diagnosis of one, two or three of these symptom-based
syndromes. This was not the case: Beck scores increased
monotonically with frequency of symptom-based syn-
dromes – a finding we have reported earlier [29].
Second, if CFS and FM were essentially the same ill-
ness, then rates of both illnesses should co-vary and rates
of each should not differ between different primary sleep
disorders. This was not the case. Rates of CFS and FM
did covary in insomnia, but rates of CFS and FM di-
verged in SDB with these patients having high rates of
CFS but rates of FM at the population norm. Finding this
difference suggests that CFS and FM have different
pathophysiological underpinnings – at least in the face
of SDB. Therefore these data argue against the “unitary”
hypothesis that CFS and FM are variants of a functional
somatic syndrome due to a psychologically based ampli-
fication of symptoms that every person experiences.
That conclusion must be tempered by the possibility that
such a mechanism could produce different symptoms in
different patients.
Despite the small sample size, finding that narcolepsy pa-
tients had predominantly CFS and not FM further supports
the idea that CFS and FM are not necessarily the same. The
fact that differences do exist between CFS and FM supports
the continued use of individual case definitions for each dis-
order and argues against modifying diagnostic criteria for
FM [30] to bring the two disorders closer together.
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ruling out underlying SDB as a possible, but unappreci-
ated, cause of apparent chronic fatigue syndrome. Current
guidelines do not recommend a formal sleep evaluation
including PSG as part of the work up to rule out medical
causes of fatigue before making the diagnosis of CFS.
However, we found that 13% of patients with PSG-proven
SDB fulfilled case criteria for CFS. In view of the fact that
the community prevalence of CFS is 0.42% [31], the rate
of 13% is greatly increased and of clinical importance. This
finding leads to two research questions. First, is it possible
to predict the existence of SDB in patients receiving the
diagnosis of CFS? Being able to make this prediction
would lead to PSG to corroborate the existence of this
sleep disorder and then to try to treat it.
Excessive daytime sleepiness as assessed by the Epworth
Sleepiness Scale has turned out to be a disappointing pre-
dictor of SDB in that the majority of SDB patients have
Epworth scores in the normal range [32]. However, the
predictability of elevated Epworth scores in identifying
SDB is greatly improved for those SDB patients who also
fulfill criteria for CFS. More than half of the 16 patients in
this group had Epworth scores >10 with the mean, median
and 75th percentile being 13.3, 16 and 17.3, respectively.
In considering these data, it would be important to know
Epworth data for CFS patients without SDB. While our
study did not provide these data, two studies do provide
such data for samples of 24 and 415 CFS patients, respect-
ively (mean = 9.4; SD = 4.5 [33]; mean = 10.5; SD = 5.5
[34]). Since available data indicate SDB to be at population
rates for CFS samples, we accept the result of these studies
as being typical of CFS patients without SDB. Epworth
scores were significantly lower by t-tests (p < 0.05) than in
the sample with SDB reported here. Thus, patients with
SDB who also fulfill criteria for CFS alone or CFS with
FM have more daytime sleepiness than CFS patients with-
out SDB.
The second research question is whether treating the
SDB in CFS-SDB patients with CPAP would produce
symptomatic improvement. While the original case defin-
ition for CFS did not require PSG in the work up of patients
with severe and chronic fatigue, the 2003 discussion of
shortcomings in that case definition [35] emphasized that
“assessment of sleep must detect treatable primary sleep
disorders and evaluate sleep-related symptoms that may be
part of CFS”. Our finding that 13% of patients with SDB
also fulfilled criteria for CFS supports that conclusion. The
data presented here suggest an algorithm to help the phy-
sician determine which CFS patient should undergo PSG
based on his/her Epworth Sleepiness Score. We recom-
mend Epworth scoring on all patients being evaluated, and
then, to reduce the risk of a negative sleep study, PSG
should be considered for the patient who fulfills criteria for
CFS and who has an Epworth score of 16 or above – i.e., atand above the 50th percentile for this group; based on
Epworth data from 415 CFS patients [34], approximately
13% of all patients would fall into this category. Using these
criteria to perform PSG in patients with the diagnosis of
CFS will allow the clinician to make the diagnosis of SDB
and then determine whether treating it may greatly reduce
the complaint of severe fatigue. This important study re-
mains to be done.
The use of antidepressants as a second possible treat-
ment for this group of patients emerges from our finding
an association of Epworth scores in patients with SDB and
CFS with high BDI scores, a measure of depressed mood.
The link between depression and excessive daytime sleepi-
ness has been shown in general population samples as
well as in those comprised of SDB patients [36-38]. This
treatment may be most effective in the subgroup of pa-
tients with both high Epworth and high BDI scores.
Strengths and Weaknesses: A major strength of this
study was the fact that we had a large sample size of 122
patients with SDB. Having so many SDB patients pro-
vided another strength in that we had an adequate sam-
ple to examine whether patients with a milder form of
SDB might differ from those with more severe SDB in
rates of CFS and/or FM. They did not. Being able to
look across the breadth of SDB helped rectify another
weakness – that FM is predominantly a disease of
women and thus might not be seen in adequate numbers
in an SDB population; however, the data were essentially
the same for the two SDB groups even though the gen-
der prevalence in the two groups did differ. One poten-
tial weakness had to do with our sample – people with
sleep complaints referred for evaluation in a sleep lab.
While the complaint of unrefreshing sleep is among the
most common symptoms of CFS [39], it is not endorsed
by all patients and so the patients studied here may have
been biased toward those with identifiable sleep disorders;
conversely, patients with CFS may have unrefreshing sleep
stemming from their other symptoms/problems such
pain, sore throat, headaches. Sample size was also a weak-
ness – at least for the small groups with IH and narco-
lepsy. Nonetheless, finding high rates of CFS in narcolepsy
was not unexpected as these patients are notable for hav-
ing marked daytime sleepiness, but the result does suggest
the possibility of misdiagnosis for some patients thought
to have CFS – further support for doing PSGs in selected
cases of excessively sleepy patients with severe fatigue. A
next step for researchers interested in the relation between
sleep and symptom-based illness will be to expand the
sample size of patients with these two sleep diagnoses.
Conclusions
A substantial number of patients with sleep disturbed
breathing fulfill criteria for the diagnosis of chronic fatigue
syndrome, but not for fibromyalgia. In contrast, patients
Pejovic et al. BMC Neurology  (2015) 15:53 Page 8 of 9with insomnia fulfill criteria for both chronic fatigue syn-
drome and fibromyalgia. The fact that rates of CFS and
FM differ in sleep disturbed breathing suggests differences
in the underlying pathophysiology between the two ill-
nesses. It will be important to identify those CFS patients
who may have sleep disturbed breathing. To do this, the
authors suggest that CFS patients complete Epworth
Sleepiness Scales. Those with values of 16 or greater
should undergo formal sleep evaluation to determine if
they have the potentially treatable condition of sleep dis-
turbed breathing.
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